5AM Venture Management, LLC Long-Term Concentrated

CIK: 0001799883 · Show all filings

Period: Q4 2019 (Next →)

Filing Date: Feb 5, 2020

Total Value ($000): $464,773 (100.0% shares, 0.0% debt)

Holdings (9)

— Aprea Therapeutics, Inc. 28.2%

Value ($000) $130,908 Shares 2,852,654 Est. Cost $45.89 Unrealized —

— Homology Medicines, Inc. 24.7%

Value ($000) $114,594 Shares 5,535,919 Est. Cost $20.70 Unrealized —

CRNX Crinetics Pharmaceuticals, Inc. 12.8%

Value ($000) $59,270 Shares 2,362,286 Est. Cost $19.04 Unrealized 0.0%

ARVN Arvinas, Inc. 12.2%

Value ($000) $56,639 Shares 1,378,423 Est. Cost $29.28 Unrealized 0.0%

CABA Cabaletta Bio, Inc. 11.0%

Value ($000) $51,260 Shares 3,669,263 Est. Cost $11.85 Unrealized 0.0%

IDYA IDEAYA Biosciences, Inc. 5.6%

Value ($000) $25,973 Shares 3,463,066 Est. Cost $7.13 Unrealized 0.0%

— scPharmaceuticals Inc. 4.0%

Value ($000) $18,414 Shares 3,253,440 Est. Cost $5.66 Unrealized —

— Cidara Therapeutics, Inc. 1.7%

Value ($000) $7,705 Shares 2,006,511 Est. Cost $3.84 Unrealized —

— Viveve Medical, Inc. 0.0%

Value ($000) $10 Shares 8,078 Est. Cost $1.24 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Aprea Therapeutics, Inc.	2,852,654	$130,908	28.2%	$45.89	—	COM	03836J102
—	Homology Medicines, Inc.	5,535,919	$114,594	24.7%	$20.70	—	COM	438083107
CRNX	Crinetics Pharmaceuticals, Inc.	2,362,286	$59,270	12.8%	$19.04	0.0%	COM	22663K107
ARVN	Arvinas, Inc.	1,378,423	$56,639	12.2%	$29.28	0.0%	COM	04335A105
CABA	Cabaletta Bio, Inc.	3,669,263	$51,260	11.0%	$11.85	0.0%	COM	12674W109
IDYA	IDEAYA Biosciences, Inc.	3,463,066	$25,973	5.6%	$7.13	0.0%	COM	45166A102
—	scPharmaceuticals Inc.	3,253,440	$18,414	4.0%	$5.66	—	COM	810648105
—	Cidara Therapeutics, Inc.	2,006,511	$7,705	1.7%	$3.84	—	COM	171757107
—	Viveve Medical, Inc.	8,078	$10	0.0%	$1.24	—	COM	92852W303